{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:13Z","timestamp":1790996773995,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aners Stiftelsen","award":["sd"],"award-info":[{"award-number":["sd"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is characterised by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta. Post-mortem data suggests that the loss of DA markers may long precede the cell death, leaving a window to rescue the DA phenotype. Screening for potential neuroprotective or restorative therapies, however, requires that partial lesions of DA neurons can be modelled in vitro. In order to establish a partial lesion model of DA neurons in vitro, we evaluated the effects of different exposure times to 1-methyl-4-phenylpyridinium (MPP<jats:sup>+<\/jats:sup>) and 6-hydroxydopamine (6-OHDA) on the cell survival and DA marker expression using DA neurons derived from the Lund human mesencephalic (LUHMES) cell line. We show that 24-h incubation with 50\u00a0\u03bcM of MPP<jats:sup>+<\/jats:sup> or 6-h incubation with 100\u00a0\u03bcM of 6-OHDA leads to a significant decrease in the protein expression of DA markers without affecting overall cell death, consistent with a mild DA lesion. Using conditioned medium of human brain\u2013derived pericytes stimulated with platelet-derived growth factor BB (PDGF-BB), we demonstrate a significant upregulation of DA markers. In conclusion, we provide an experimental model of an in vitro DA neuron partial lesion suitable to study different molecules and their potential neuroprotective or neurorestorative effects on the DA phenotype. We provide evidence that the secretome of brain pericytes stimulated via PDGF-BB\/PDGFR\u03b2 affects DA marker expression and may represent one possible mechanism contributing to the neurorestoration previously observed in PD by this growth factor.<\/jats:p>","DOI":"10.1007\/s12031-020-01589-6","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T21:11:43Z","timestamp":1590786703000},"page":"1914-1925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["An In Vitro Partial Lesion Model of Differentiated Human Mesencephalic Neurons: Effect of Pericyte Secretome on Phenotypic Markers"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2801-7392","authenticated-orcid":false,"given":"Abderahim","family":"Gaceb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Barbariga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"1589_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A et al (2010) Pericytes regulate the blood-brain barrier. Nature 468:557\u2013561. https:\/\/doi.org\/10.1038\/nature09522","journal-title":"Nature"},{"key":"1589_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","volume":"68","author":"RD Bell","year":"2010","unstructured":"Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68:409\u2013427. https:\/\/doi.org\/10.1016\/j.neuron.2010.09.043","journal-title":"Neuron"},{"key":"1589_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1215\/S1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7:452\u2013464. https:\/\/doi.org\/10.1215\/S1152851705000232","journal-title":"Neuro Oncol"},{"key":"1589_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","volume":"65","author":"D Blum","year":"2001","unstructured":"Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease. Prog Neurobiol 65:135\u2013172","journal-title":"Prog Neurobiol"},{"key":"1589_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbr.2015.01.053","volume":"284","author":"J Boix","year":"2015","unstructured":"Boix J, Padel T, Paul G (2015) A partial lesion model of Parkinson\u2019s disease in mice--characterization of a 6-OHDA-induced medial forebrain bundle lesion. Behav Brain Res 284:196\u2013206. https:\/\/doi.org\/10.1016\/j.bbr.2015.01.053","journal-title":"Behav Brain Res"},{"key":"1589_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","volume":"211","author":"J Bove","year":"2012","unstructured":"Bove J, Perier C (2012) Neurotoxin-based models of Parkinson\u2019s disease. Neuroscience 211:51\u201376. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.10.057","journal-title":"Neuroscience"},{"key":"1589_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","volume":"3","author":"M Crisan","year":"2008","unstructured":"Crisan M et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301\u2013313. https:\/\/doi.org\/10.1016\/j.stem.2008.07.003","journal-title":"Cell Stem Cell"},{"key":"1589_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468:562\u2013566. https:\/\/doi.org\/10.1038\/nature09513","journal-title":"Nature"},{"key":"1589_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"1589_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-030-02601-1_11","volume":"1109","author":"A Gaceb","year":"2018","unstructured":"Gaceb A, Paul G (2018) Pericyte secretome. Adv Exp Med Biol 1109:139\u2013163. https:\/\/doi.org\/10.1007\/978-3-030-02601-1_11","journal-title":"Adv Exp Med Biol"},{"key":"1589_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/0271678X17719645","volume":"38","author":"A Gaceb","year":"2018","unstructured":"Gaceb A, Ozen I, Padel T, Barbariga M, Paul G (2018) Pericytes secrete pro-regenerative molecules in response to platelet-derived growth factor-BB. J Cereb Blood Flow Metab 38:45\u201357. https:\/\/doi.org\/10.1177\/0271678X17719645","journal-title":"J Cereb Blood Flow Metab"},{"key":"1589_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.yexcr.2011.12.005","volume":"318","author":"I Guijarro-Munoz","year":"2012","unstructured":"Guijarro-Munoz I, Cuesta AM, Alvarez-Cienfuegos A, Geng JG, Alvarez-Vallina L, Sanz L (2012) The axonal repellent Slit2 inhibits pericyte migration: potential implications in angiogenesis. Exp Cell Res 318:371\u2013378. https:\/\/doi.org\/10.1016\/j.yexcr.2011.12.005","journal-title":"Exp Cell Res"},{"key":"1589_CR13","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1074\/jbc.M113.521161","volume":"289","author":"I Guijarro-Munoz","year":"2014","unstructured":"Guijarro-Munoz I, Compte M, Alvarez-Cienfuegos A, Alvarez-Vallina L, Sanz L (2014) Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-kappaB signaling pathway and proinflammatory response in human pericytes. J Biol Chem 289:2457\u20132468. https:\/\/doi.org\/10.1074\/jbc.M113.521161","journal-title":"J Biol Chem"},{"key":"1589_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.stem.2016.12.006","volume":"20","author":"N Guimaraes-Camboa","year":"2017","unstructured":"Guimaraes-Camboa N et al (2017) Pericytes of multiple organs do not behave as mesenchymal stem cells in vivo. Cell Stem Cell 20:345\u2013359 e345. https:\/\/doi.org\/10.1016\/j.stem.2016.12.006","journal-title":"Cell Stem Cell"},{"key":"1589_CR15","doi-asserted-by":"publisher","unstructured":"Harischandra DS et al (2019) Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson\u2019s disease. Biochim Biophys Acta Mol Basis Dis:165533. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165533","DOI":"10.1016\/j.bbadis.2019.165533"},{"key":"1589_CR16","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1073\/pnas.93.4.1518","volume":"93","author":"M Hoshimaru","year":"1996","unstructured":"Hoshimaru M, Ray J, Sah DW, Gage FH (1996) Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci U S A 93:1518\u20131523","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1589_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"KA Jellinger","year":"1991","unstructured":"Jellinger KA (1991) Pathology of Parkinson\u2019s disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153\u2013197","journal-title":"Mol Chem Neuropathol"},{"key":"1589_CR18","doi-asserted-by":"publisher","first-page":"9459","DOI":"10.1038\/s41598-017-09528-z","volume":"7","author":"X Kang","year":"2017","unstructured":"Kang X et al (2017) Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype. Sci Rep 7:9459. https:\/\/doi.org\/10.1038\/s41598-017-09528-z","journal-title":"Sci Rep"},{"key":"1589_CR19","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH et al (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136:2419\u20132431. https:\/\/doi.org\/10.1093\/brain\/awt192","journal-title":"Brain"},{"key":"1589_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","volume":"11","author":"NW Kowall","year":"2000","unstructured":"Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ (2000) MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport 11:211\u2013213. https:\/\/doi.org\/10.1097\/00001756-200001170-00041","journal-title":"Neuroreport"},{"key":"1589_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","volume":"292","author":"JW Langston","year":"1984","unstructured":"Langston JW, Forno LS, Rebert CS, Irwin I (1984) Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res 292:390\u2013394. https:\/\/doi.org\/10.1016\/0006-8993(84)90777-7","journal-title":"Brain Res"},{"key":"1589_CR22","first-page":"189","volume":"12","author":"YS Lau","year":"1991","unstructured":"Lau YS, Fung YK, Trobough KL, Cashman JR, Wilson JA (1991) Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurotoxicology 12:189\u2013199","journal-title":"Neurotoxicology"},{"key":"1589_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0079-6123(08)60902-4","volume":"84","author":"B Lindh","year":"1990","unstructured":"Lindh B, Hokfelt T (1990) Structural and functional aspects of acetylcholine peptide coexistence in the autonomic nervous system. Prog Brain Res 84:175\u2013191","journal-title":"Prog Brain Res"},{"key":"1589_CR24","doi-asserted-by":"publisher","first-page":"38884","DOI":"10.1074\/jbc.M205518200","volume":"277","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P (2002) Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 277:38884\u201338894. https:\/\/doi.org\/10.1074\/jbc.M205518200","journal-title":"J Biol Chem"},{"key":"1589_CR25","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1523\/JNEUROSCI.1746-05.2005","volume":"25","author":"J Lotharius","year":"2005","unstructured":"Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, Brundin P, Leist M (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25:6329\u20136342. https:\/\/doi.org\/10.1523\/JNEUROSCI.1746-05.2005","journal-title":"J Neurosci"},{"key":"1589_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1126\/science.2536956","volume":"243","author":"T Matsui","year":"1989","unstructured":"Matsui T et al (1989) Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243:800\u2013804. https:\/\/doi.org\/10.1126\/science.2536956","journal-title":"Science"},{"key":"1589_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-2004-813795","volume":"25","author":"E Oschatz","year":"2004","unstructured":"Oschatz E, Prosch H, Schober E, Mostbeck G (2004) Evaluation of a portable ultrasound device immediately after spiral computed tomography. Ultraschall Med 25:433\u2013437. https:\/\/doi.org\/10.1055\/s-2004-813795","journal-title":"Ultraschall Med"},{"key":"1589_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nbd.2016.06.002","volume":"94","author":"T Padel","year":"2016","unstructured":"Padel T, Ozen I, Boix J, Barbariga M, Gaceb A, Roth M, Paul G (2016) Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson\u2019s disease. Neurobiol Dis 94:95\u2013105. https:\/\/doi.org\/10.1016\/j.nbd.2016.06.002","journal-title":"Neurobiol Dis"},{"key":"1589_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/ejn.14102","volume":"49","author":"G Paul","year":"2019","unstructured":"Paul G, Sullivan AM (2019) Trophic factors for Parkinson\u2019s disease: where are we and where do we go from here? Eur J Neurosci 49:440\u2013452. https:\/\/doi.org\/10.1111\/ejn.14102","journal-title":"Eur J Neurosci"},{"key":"1589_CR30","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI79635","volume":"125","author":"G Paul","year":"2015","unstructured":"Paul G, Zachrisson O, Varrone A, Almqvist P, Jerling M, Lind G, Rehncrona S, Linderoth B, Bjartmarz H, Shafer LL, Coffey R, Svensson M, Mercer KJ, Forsberg A, Halldin C, Svenningsson P, Widner H, Fris\u00e9n J, P\u00e5lhagen S, Haegerstrand A (2015) Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson\u2019s disease patients. J Clin Invest 125:1339\u20131346. https:\/\/doi.org\/10.1172\/JCI79635","journal-title":"J Clin Invest"},{"key":"1589_CR31","first-page":"S173","volume":"28","author":"G Paul-Visse","year":"2013","unstructured":"Paul-Visse G et al (2013) Safety and efficacy of recombinant human platelet derived growth factor BB (rhPDGF-BB) in Parkinson\u2019s disease. Movement Disord 28:S173\u2013S173","journal-title":"Movement Disord"},{"key":"1589_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.neuro.2011.12.007","volume":"33","author":"D Poltl","year":"2012","unstructured":"Poltl D, Schildknecht S, Karreman C, Leist M (2012) Uncoupling of ATP-depletion and cell death in human dopaminergic neurons. Neurotoxicology 33:769\u2013779. https:\/\/doi.org\/10.1016\/j.neuro.2011.12.007","journal-title":"Neurotoxicology"},{"key":"1589_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/bf03033178","volume":"5","author":"SP Presgraves","year":"2004","unstructured":"Presgraves SP, Ahmed T, Borwege S, Joyce JN (2004) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5:579\u2013598. https:\/\/doi.org\/10.1007\/bf03033178","journal-title":"Neurotox Res"},{"key":"1589_CR34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/toxsci\/kfl133","volume":"95","author":"JR Richardson","year":"2007","unstructured":"Richardson JR et al (2007) Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Sci 95:196\u2013204. https:\/\/doi.org\/10.1093\/toxsci\/kfl133","journal-title":"Toxicol Sci"},{"key":"1589_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.33549\/physiolres.933895","volume":"68","author":"S Salari","year":"2019","unstructured":"Salari S, Bagheri M (2019) In vivo, in vitro and pharmacologic models of Parkinson\u2019s disease. Physiol Res 68:17\u201324. https:\/\/doi.org\/10.33549\/physiolres.933895","journal-title":"Physiol Res"},{"key":"1589_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.taap.2009.07.027","volume":"241","author":"S Schildknecht","year":"2009","unstructured":"Schildknecht S et al (2009) Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. Toxicol Appl Pharmacol 241:23\u201335. https:\/\/doi.org\/10.1016\/j.taap.2009.07.027","journal-title":"Toxicol Appl Pharmacol"},{"key":"1589_CR37","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1242\/jcs.1125880","volume":"126","author":"ME Seward","year":"2013","unstructured":"Seward ME et al (2013) Amyloid-beta signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer\u2019s disease. J Cell Sci 126:1278\u20131286. https:\/\/doi.org\/10.1242\/jcs.1125880","journal-title":"J Cell Sci"},{"key":"1589_CR38","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s00204-015-1637-z","volume":"90","author":"L Smirnova","year":"2016","unstructured":"Smirnova L et al (2016) A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis. Arch Toxicol 90:2725\u20132743. https:\/\/doi.org\/10.1007\/s00204-015-1637-z","journal-title":"Arch Toxicol"},{"key":"1589_CR39","doi-asserted-by":"publisher","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol:106, 17\u2013107, 32. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.04.004","DOI":"10.1016\/j.pneurobio.2013.04.004"},{"key":"1589_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/syn.20089","volume":"55","author":"Z Xu","year":"2005","unstructured":"Xu Z, Cawthon D, McCastlain KA, Slikker W Jr, Ali SF (2005) Selective alterations of gene expression in mice induced by MPTP. Synapse 55:45\u201351. https:\/\/doi.org\/10.1002\/syn.20089","journal-title":"Synapse"},{"key":"1589_CR41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1634\/stemcells.2004-0365","volume":"23","author":"Y Yan","year":"2005","unstructured":"Yan Y et al (2005) Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23:781\u2013790. https:\/\/doi.org\/10.1634\/stemcells.2004-0365","journal-title":"Stem Cells"},{"key":"1589_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2006.02.002","volume":"200","author":"U Yazdani","year":"2006","unstructured":"Yazdani U, German DC, Liang CL, Manzino L, Sonsalla PK, Zeevalk GD (2006) Rat model of Parkinson\u2019s disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+). Exp Neurol 200:172\u2013183. https:\/\/doi.org\/10.1016\/j.expneurol.2006.02.002","journal-title":"Exp Neurol"},{"key":"1589_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3233\/JPD-2011-0003","volume":"1","author":"O Zachrisson","year":"2011","unstructured":"Zachrisson O et al (2011) Restorative effects of platelet derived growth factor-BB in rodent models of Parkinson\u2019s disease. J Parkinsons Dis 1:49\u201363. https:\/\/doi.org\/10.3233\/JPD-2011-0003","journal-title":"J Parkinsons Dis"},{"key":"1589_CR44","doi-asserted-by":"publisher","first-page":"175909141877743","DOI":"10.1177\/1759091418777438","volume":"10","author":"XS Zeng","year":"2018","unstructured":"Zeng XS, Geng WS, Jia JJ (2018) Neurotoxin-induced animal models of parkinson disease: pathogenic mechanism and assessment. ASN Neuro 10:1759091418777438. https:\/\/doi.org\/10.1177\/1759091418777438","journal-title":"ASN Neuro"},{"key":"1589_CR45","first-page":"195","volume":"12","author":"S Zhang","year":"2009","unstructured":"Zhang S, Liu XZ, Liu ZL, Wang YM, Hu QL, Ma TZ, Sun SZ (2009) Stem cells modified by brain-derived neurotrophic factor to promote stem cells differentiation into neurons and enhance neuromotor function after brain injury. Chin J Traumatol 12:195\u2013199","journal-title":"Chin J Traumatol"},{"key":"1589_CR46","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/aps.2014.36","volume":"35","author":"XM Zhang","year":"2014","unstructured":"Zhang XM, Yin M, Zhang MH (2014) Cell-based assays for Parkinson\u2019s disease using differentiated human LUHMES cells. Acta Pharmacol Sin 35:945\u2013956. https:\/\/doi.org\/10.1038\/aps.2014.36","journal-title":"Acta Pharmacol Sin"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01589-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:18:08Z","timestamp":1622247488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01589-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1589"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01589-6","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}